Vascular endothelial growth factor gene therapy (Valentis)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVascular endothelial growth factor gene therapy (Valentis)
Drug Alias NameVEGF-165 gene therapy - Valentis
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transferenceAngiogenesis inducers
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsPeripheral Vascular DiseasesMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesValentisUniversity Of Eastern Finland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValentisUniversity Of Eastern Finland
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A